Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.76
-0.07 (-0.42%)
May 13, 2026, 4:00 PM EDT - Market closed

Burning Rock Biotech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
539.57515.82537.44563.24507.86
Revenue Growth (YoY)
4.60%-4.02%-4.58%10.90%18.13%
Cost of Revenue
136.65153.42174.21183.2143.72
Gross Profit
402.91362.4363.23380.04364.15
Selling, General & Admin
-291.27-452.54-685.53-938.58-793.35
Research & Development
-166.49-232.29-347.02-421.87-367.86
Other Operating Expenses
--35.13---
Total Operating Expenses
-457.76-719.96-1,033-1,360-1,161
Operating Income
-54.85-357.56-669.32-980.41-797.06
Interest Income
8.0512.2117.969.363.46
Interest Expense
-0.03--0.1-1.54
Other Non-Operating Income (Expense)
-6.974.610.061.7-0.66
Total Non-Operating Income (Expense)
1.0616.8218.0211.161.27
Pretax Income
-53.79-340.74-651.3-969.25-795.8
Provision for Income Taxes
-1.56-5.89-2.39-1.99-0.9
Net Income
-55.35-346.63-653.69-971.23-796.7
Net Income to Common
-55.35-346.63-653.69-971.23-796.7
Shares Outstanding (Basic)
99999
Shares Outstanding (Diluted)
99999
Shares Change (YoY)
3.94%0.63%-1.75%-0.34%69.33%
EPS (Basic)
-5.20-33.70-63.80-93.50-76.50
EPS (Diluted)
-5.20-33.70-63.80-93.50-76.50
Shares Outstanding
10.5210.7610.2410.26105.11
Free Cash Flow
-33.69-97.68-263.89-527.1-688.81
Free Cash Flow Per Share
-3.79-11.41-31.02-60.88-79.28
Gross Margin
74.67%70.26%67.59%67.47%71.70%
Operating Margin
-10.16%-69.32%-124.54%-174.07%-156.94%
Profit Margin
-10.26%-67.20%-121.63%-172.44%-156.87%
FCF Margin
-6.24%-18.94%-49.10%-93.58%-135.63%
EBITDA
-33.08-305.36-535.92-856.31-749.3
EBITDA Margin
-6.13%-59.20%-99.72%-152.03%-147.54%
EBIT
-54.85-357.56-669.32-980.41-797.06
EBIT Margin
-10.16%-69.32%-124.54%-174.07%-156.94%
Effective Tax Rate
2.89%1.73%0.37%0.20%0.11%
Updated Mar 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q